• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND RESOLUTE ONYX RX; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND RESOLUTE ONYX RX; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number RONYX30018UX
Medical Device Problem Code Device Dislodged or Dislocated (2923)
Health Effect - Clinical Code Insufficient Information (4580)
Date of Event 05/18/2022
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Additional information: it was reported that two resolute onyx stents dislodged in vivo during a procedure.A resolute onyx stent was returned for evaluation.The lot number was different to the two lot numbers reported.Product analysis: the stent was not present on the balloon and did not return for analysis.A pin hole tear was evident on the distal shaft.The tear did not penetrate through to the inner member.Blood was visible on the lumen.Blood was visible in the balloon.The balloon folds remained intact.Crimp impressions were visible on the exposed balloon surface.Deformation evident to the distal tip.The inner lumen patency was verified with a 0.015 inch mandrel.No other damage evident to the remainder of the device.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event or Problem Description
During a procedure an attempt was made to use two resolute onyx coronary drug eluting stents, to treat a moderately tortuous, moderately calcified lesion exhibiting 90% stenosis located in the mid left anterior descending (lad) artery.The devices were removed from the hoop with no issues.The devices were inspected before use with no issues noted.The devices were prepped per ifu with no issues.The lesion was pre-dilated.The devices did pass through a previously deployed stent.Resistance was encountered when advancing the devices.Excessive force was not used during delivery.It was reported that both stents dislodged during delivery to the lesion.It was stated that both stents dislodged in the lad, one mid lesion and the other more distal in the lesion.The stents were not removed and were crushed in the artery.The patient was reported to be alive with no further injury.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RESOLUTE ONYX RX
Common Device Name
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
EI 
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
EI  
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key15348357
Report Number9612164-2022-03278
Device Sequence Number20093146
Product Code NIQ
UDI-Device Identifier00643169556997
UDI-Public00643169556997
Combination Product (Y/N)N
Initial Reporter StateGA
Initial Reporter CountryUS
PMA/510(K) Number
P160043
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 09/02/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date11/25/2024
Device Model NumberRONYX30018UX
Device Lot Number0010954130
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/18/2022
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 08/05/2022
Initial Report FDA Received Date09/02/2022
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured11/26/2021
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age81 YR
Patient SexMale
Patient Weight82 KG
-
-